ciprofloxacin has been researched along with Urinary Bladder, Neurogenic in 8 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of low-dose long-term treatment with ciprofloxacin in the prevention of recurrent urinary tract infections in patients with spinal cord lesions and neurogenic bladder dysfunction, a prospective, randomized, cross-over, placebo-controlled study was performed." | 5.07 | Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. ( Biering-Sørensen, F; Bruun, B; Høiby, N; Nordenbo, A; Rahm, V; Ravnborg, M, 1994) |
| "Multi-resistant nosocomial urinary tract infections occurring in thirty patients with neurogenic bladder dysfunction were treated with ciprofloxacin 100 mg twice daily Early bacteriological eradication was obtained in 48." | 5.06 | Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. ( Baert, L; van Poppel, H, 1987) |
| "A study was performed in 25 men with spinal cord injuries undergoing intermittent catheterization whose urine had > or = 10(5) bacterial colonies/ml to determine efficacy of ciprofloxacin in eradicating susceptible organisms from urine, urethra, and perineum." | 3.70 | Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury. ( Brookings, ES; Canupp, KC; DeVivo, MJ; Waites, KB, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frazzini, V | 1 |
| Capasso, M | 1 |
| Onofrj, M | 1 |
| Khan, MH | 1 |
| Baldo, O | 1 |
| Koenig, P | 1 |
| Shaikh, N | 1 |
| Krasemann, C | 1 |
| Von Poppel, H | 1 |
| Wegge, M | 2 |
| Chysky, V | 2 |
| Biering-Sørensen, F | 1 |
| Høiby, N | 1 |
| Nordenbo, A | 1 |
| Ravnborg, M | 1 |
| Bruun, B | 1 |
| Rahm, V | 1 |
| Waites, KB | 1 |
| Canupp, KC | 1 |
| Brookings, ES | 1 |
| DeVivo, MJ | 1 |
| Van Poppel, H | 2 |
| Willemen, P | 1 |
| Kraseman, P | 1 |
| Baert, L | 2 |
| Boerema, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial[NCT05519072] | Phase 4 | 140 participants (Anticipated) | Interventional | 2022-08-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ciprofloxacin and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion.
Topics: Adult; Aged; Alanine Transaminase; Ciprofloxacin; Double-Blind Method; Feces; Female; Follow-Up Stud | 1994 |
Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder.
Topics: Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Female; Humans; Male; Microbial Sensiti | 1990 |
Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; M | 1987 |
5 other studies available for ciprofloxacin and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
An Uncommon Case of Hyperammonemic Encephalopathy.
Topics: Accidental Falls; Anti-Bacterial Agents; Brain Diseases; Ciprofloxacin; Dehydration; Electroencephal | 2019 |
Use of prophylactic antibiotics for intra-vesicle Botox® injection.
Topics: Acetylcholine Release Inhibitors; Administration, Intravesical; Anti-Bacterial Agents; Antibiotic Pr | 2017 |
Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Controlled Clinical Trials as Topic; Female; Huma | 1989 |
Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Humans; Male; M | 1999 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxa | 1986 |